SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-14-000035
Filing Date
2014-01-22
Accepted
2014-01-22 15:28:07
Documents
1
Group Members
DOMINIQUE SEMONMERLIN NEXUS IV, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss200059_sc13ga.htm SC 13G/A 128094
  Complete submission text file 0000947871-14-000035.txt   129492
Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 457-4670
STEM CELL THERAPEUTICS CORP (Subject) CIK: 0001392333 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87793 | Film No.: 14540251

Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169
Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270
Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A